BCG Oncology, PC

Phoenix, Arizona 85032

0 studies enrolling now · 4 studies all time

What they study most

Bladder Cancer, Bladder Neoplasm, Cancer of the Bladder, Carcinoma in Situ, Malignant Tumor of the Urinary Bladder, Mycobacterium, Neoplasm Recurrence, Local, Superficial Bladder Cancer, Transitional Cell, Carcinoma, Urinary Bladder Cancer, Urinary Bladder Neoplasm, Urogenital Neoplasms

Studies at this site

• Evaluation of NanoDoce® in Participants With Urothelial Carcinoma — Completed
• A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) — Stopped early
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer — Stopped early
• Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer — Completed